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Abstract
Background: Co-expression based Cancer Modules (CMs) are sets of genes that act in concert to carry out specific
functions in different cancer types, and are constructed by exploiting gene expression profiles related to specific
clinical conditions or expression signatures associated to specific processes altered in cancer. Unfortunately, genes
involved in cancer are not always detectable using only expression signatures or co-expressed sets of genes, and
in principle other types of functional interactions should be exploited to obtain a comprehensive picture of the
molecular mechanisms underlying the onset and progression of cancer.
Results: We propose a novel semi-supervised method to rank genes with respect to CMs using networks
constructed from different sources of functional information, not limited to gene expression data. It exploits on the
one hand local learning strategies through score functions that extend the guilt-by-association approach, and on
the other hand global learning strategies through graph kernels embedded in the score functions, able to take
into account the overall topology of the network. The proposed kernelized score functions compare favorably with
other state-of-the-art semi-supervised machine learning methods for gene ranking in biological networks and
scales well with the number of genes, thus allowing fast processing of very large gene networks.
Conclusions: The modular nature of kernelized score functions provides an algorithmic scheme from which
different gene ranking algorithms can be derived, and the results show that using integrated functional networks
we can successfully predict CMs defined mainly through expression signatures obtained from gene expression data
profiling. A preliminary analysis of top ranked “false positive” genes shows that our approach could be in
perspective applied to discover novel genes involved in the onset and progression of tumors related to specific
CMs.
Background
Large scale projects aimed at the elucidation of the
molecular mechanisms underlying tumors onset and
progression play a crucial role to improve clinicians abil-
ity to treat cancer [1]. The huge amount of data pro-
duced by these research projects yielded to the
development of specialized data repositories enabling
researchers to mine effectively cancer expression related
data like ONCOMINE [2], and to collect and organize
information about the gene expression profiles of nor-
mal, pre-cancer, and cancer cells as in the case of the
Cancer Genome Anatomy Project (CGAP). Cancer spe-
cific gene expression data can also be found in the Gene
Expression Omnibus (GEO) repository [3]. The avail-
ability of this unprecedented volume of data has, on the
one hand, the potential to boost the research focused on
the elucidation of the molecular basis of cancer and, on
the other hand, to accelerate the development of novel
cancer therapies.
Even if novel bio-technologies, such as Next Genera-
tion Sequencing and epigenetic pattern analysis, have
been recently applied to cancer research [4], a funda-
mental contribution in this research area is still due to
the application of gene expression profiling. This techni-
que proved to be effective for the classification of
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diverse types of tumors [5], for the prediction of patients
outcome [6] and the prediction of the response to che-
motherapies [7,8].
By exploiting gene expression profiling, Segal and col-
leagues constructed a functional module map for can-
cers to investigate commonalities and variations
between different types of tumor [9]. The novelty of
their approach lies in the analysis of expression profiles
for the identification of sets of genes that act in concert
to carry out specific functions in different cancer types,
and in the construction of a module map constituted by
a collection of the gene sets associated to specific Can-
cer gene Modules (CMs, hereafter). The rationale
behind this approach is that the comparison of molecu-
lar profiles can reveal both the existence of specific pat-
terns (represented in this case by the expression
profiles) and the biological behavior of distinct tumor
types, without the need to integrate other sources of
information, such as gene regulatory networks or mole-
cular pathways, known to be relevant for the molecular
characterization of cancer.
Despite the identification of Cancer Modules based on
a single type of molecular evidence reduces the com-
plexity of the problem, this approach introduces also
serious limitations. Indeed the CMs are identified con-
sidering only transcriptional signatures, but it is com-
monly accepted that some of the aberrations leading to
cancer onset and driving their progression do not occur
at transcription level [10]. A second and more important
limitation regards the interpretability of CMs: being
derived from transcriptional data only, the functional
interpretation of the CMs cannot be easily translated
into a wider biological context, since other molecular
processes, ranging from post-transcriptional to transla-
tional and post-translational events may finely regulate
the final product of genes. For instance, gene transcripts
must be translated into proteins by the ribosomes and
misregulations of this important process can contribute
to several diseases, including cancer [11-13].
As a consequence, gene expression data alone, even if
fundamental to identify CMs, cannot detect genes
involved, for instance, in post-transcriptional misregu-
lated processes underlying cancer. To this end we need
other sources of data (i.e. protein-protein interactions,
metabolomic data and many others) to confirm CMs
identified mainly through transcriptional data, and to
discover novel genes, not detectable with gene expres-
sion profiling, related to the molecular pathology of
tumors.
In this contribution we test the hypothesis that the
CMs published in [9] can be predicted through net-
work-based algorithms using different sources of func-
tional interaction data, not limited to correlations
between expression profiles. To this end we integrated
functional interaction networks derived from Reactome
and other curated databases, and from uncurated pair-
wise relationships (e.g. protein-protein and protein
domain-domain interactions), from protein complexes
and from comparative genomics techniques [14,15].
Moreover we propose a novel algorithm to rank genes
with respect to their potential membership to each spe-
cific CM. The different ranking methods proposed in
the literature in general exploit local or global learning
strategies to properly rank genes/nodes in a biomolecu-
lar network [16-19]. In this paper we propose a ranking
method that combines both local and global learning
strategies to exploit both “local” similarities between
genes and “global” similarities embedded in the topology
of the network. Indeed our proposed kernelized score
functions adopt both local learning strategies based on a
generalized notion of distance in a universal reproducing
kernel Hilbert space, and global learning strategies based
on the choice of proper graph kernels to exploit the
overall topology of the underlying biological network.
Moreover our proposed approach is modular and exten-
sible, in the sense that different variants of both local
and global learning strategies can be chosen to design
different gene ranking algorithms. Our networks-based
algorithms are not only able to recover the CMs by
using functional networks resulting from different
sources of biomolecular data, but in perspective they
could be also applied to discover novel genes involved
in the onset and progression of tumors related to speci-
fic CMs.
Methods
In this section at first we describe the Cancer gene
Modules (CMs) proposed in [9] and the functional
interaction networks used in our experiments to rank
genes according to their likelihood to belong to specific
CMs. Then we propose a fast semi-supervised machine
learning method based on kernelized score functions to
rank genes with respect to Cancer Modules: the pro-
posed approach adopts both local and global learning
strategies able to exploit different notions of functional
similarity between genes and the overall functional rela-
tionships between genes encoded in the topology of the
network. We also briefly summarize two state-of-art
semi-supervised machine learning methods for node
ranking in biomolecular networks, i.e. the GeneMANIA
[18], and the LabProp algorithms [17], and finally we
introduce the integration techniques adopted to com-
bine the functional interaction networks.
All the methods described below process an undir-
ected weighted graph G = <V, E >, where V is the set of
vertices representing genes and E the set of edges repre-
senting functional similarity between pairs of genes. For
the sake of simplicity we denote with v Î V both a
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vertex of the graph and the corresponding associated
gene. W is the corresponding adjacency matrix with ele-
ments wij representing the “strength” of the similarity
between vertices vi, vj Î V, and VC ⊂ V is a subset of
genes belonging to a given Cancer Module.
Cancer gene modules
The CMs [9] were obtained from the Molecular Signa-
tures Database, MSigDB [20] (class: C4 (computational
gene sets), set name: CM Cancer Modules). In [9] Segal
and colleagues investigated the expression profiles of
14145 genes in 1975 arrays spanning 17 clinical cate-
gories represented by several types of tumour. To this
end the authors collected 2849 publicly available gene
sets and identified the arrays in which each gene set
shows an expression signature (coordinated over or
under expression) of a consistent part of the genes
belonging to the considered gene set. Problems due to
consistent overlaps between the signatures associated to
different gene sets were solved by clustering the gene
sets on the basis of their core signatures. This led to the
definition of 456 statistically significant gene sets called
modules by the authors (see [9] for further details). In
the second step of their analysis the authors used these
modules to characterize clinical conditions associated to
the arrays, according to the combination of modules
that are activated and deactivated. This work has the
merit to be among the first that tried to investigate
commonalities and variations between different types of
tumour in terms of sets of altered functional gene
modules.
Functional interactions networks
In this section we describe the functional gene networks
used in our tests and the reasons motivating their usage
with respect to the prediction of the CMs identified in
[9]. We used both protein-protein and domain-domain
interaction networks enforced through the predictions
of a classifier [14], and functional interaction networks
constructed with comparative genomics techniques [15].
Computationally predicted functional protein interaction
network
In [14] Wu and colleagues constructed a functional pro-
tein interaction network (FI) based on functional inter-
actions predicted by a Naive Bayes classifier (NBC)
trained on pairwise relationships extracted from Reac-
tome [21] and other curated pathways databases, and
from uncurated pairwise relationships derived from phy-
sical protein-protein interactions (PPI) in human and
other species, from gene co-expression data, proteins
domain-domain interactions, protein interactions
obtained via biomedical text mining, and Gene Ontology
annotations. The constructed network was then applied
to the study of several types of tumors (with a focus on
Glioblastoma multiforme).
The rationale behind this approach is that the usage of
a classifier able to predict the occurrence of a true func-
tional interaction (which is not directly implied by the
observation of a PPI) can be exploited in the construc-
tion of a functional interaction network that combines
high-coverage unreliable pairwise interactions datasets
with low-coverage highly reliable pathway-based func-
tional interactions. This network was used in our experi-
ments because the classifier trained on many and
diverse datasets can embed in the predicted functional
interaction links not only information derived from
human gene co-expression data but also from protein-
protein and protein domain-domain interactions.
Comparative genomics based enrichment of functional
interaction networks
Similar in spirit to the approach in [14], the functional
network construction method presented in [15] by Lee
and colleagues integrates diverse lines of evidence in
order to produce a functional human gene network
(HumanNet) that has then been used in several tests to
predict causal genes for human diseases and to increase
the power of genome-wide association studies. Human-
Net and FI networks include different sources of func-
tional interaction evidences: e.g. protein domain-domain
interactions data are not involved in the construction of
HumanNet and data about protein complexes are not
considered in the construction of the FI network.
The most significant difference between the two net-
works consists in the inclusion in HumanNet of func-
tional interactions borrowed from other species through
comparative genomics techniques: functional interac-
tions have been propagated from yeast, fly and worm to
human by means of a comparative genomics approach
presented in [22,23] and previously validated in other
species [24,25].
Score functions based on kernelized similarity measures
Kernelized score functions are based on: a) score func-
tions that generalize the guilt-by-association approach
[16,26] by introducing different functions to quantify
the similarity between a gene and its neighbours in a
biomolecular network; b) an extended notion of similar-
ity between genes implemented through kernels
embedded in the score functions. The approach is mod-
ular, in the sense that the score functions are designed
for general kernels, and specific kernels can be applied
or specifically designed to represent similarities between
genes connected in functional networks. The proposed
algorithm is fast and scales well with large functional
networks. A schematic overview of the proposed proce-
dure is depicted in Figure 1.
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More precisely, by this approach we can derive score
functions S: V ® ℝ+ based on properly chosen kernel
functions, by which we can directly rank vertices accord-
ing to the values of S(v): the higher the score, the higher
the likelihood that a gene belongs to a given Cancer
Module. From this standpoint our approach is related to,
and can be considered an extension of a method recently
proposed in the different context of gene function predic-
tion from synthetic lethality networks [27].
The score functions are built on distance measures
defined in a suitable Hilbert space ℋ and computed
using the usual “kernel trick”, by which instead of expli-
citly computing the inner product <  (·),  (·) > in the
Hilbert space, with : V ® ℋ, we compute the asso-
ciated kernel function K: V × V ® ℝ+ in the original
input space V . Let be D(v, VC) a suitable distance mea-
sure in the Hilbert space between a given vertex/gene v
and the set of genes VC belonging to a specific Cancer
Module. We chose three different distance measures:
DAV(v, VC) =
1
|VC|
∑
x∈VC
||φ(v) − φ(x)||2 (1)
DNN(v, VC) = min
x∈VC
||φ(v) − φ(x)||2 (2)
DkNN(v, VC) =
∑
x∈Ik(v)
||φ(v) − φ(x)||2 (3)
where Ik(v) in (3) represents the first ranked k vertices
x Î VC according to K(v, x). These distances represent
respectively the average, the nearest-neighbors and the
k-nearest-neighbors distance in ℋ of the vertex v w.r.t.
the set of vertices VC. From these distances we can
derive three score measures, respectively the Average
score, the Nearest Neighbours and the K-Nearest Neigh-
bours scores.
Average score. By developing the square in (1) we
obtain:
DAV(v, VC) =< φ(v),φ(v) > +
1
|VC|
∑
x∈VC
< φ(x),φ(x) > − 2|VC|
∑
x∈VC
< φ(v),φ(x) > (4)
By recalling that <(·), (·) >= K(·,·), to obtain a simi-
larity measure we need only to change the sign of (4):
Figure 1 Overview of the main logical steps of the proposed method. I) Top left: the original graph representing functional interactions
between genes. White nodes correspond to labeled examples (genes belonging to a given CM), gray nodes to unlabeled examples. II) Top
right: the “augmented” graph obtained by applying a 2-step random walk kernel. Red edges represent the new connections between genes
added by the random walk kernel. III) Bottom left: genes scoring. The score function is applied to 4 coloured nodes: the weights of the edges
(outlined in boldface) connecting the coloured nodes to the labeled “positive” nodes are added to obtain the scores associated to each
coloured node. IV) Bottom right: gene ranking. The coloured nodes are ranked according to the previously computed scores.
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SimAV(v, VC) = −K(v, v) + 2|VC|
∑
x∈VC
K(v, x) − 1|VC|
∑
x∈VC
K(x, x) (5)
By observing that the third term of (5) is equal for all
v Î V , we can obtain the following Average score SAV:
SAV(v, VC) = −K(v, v) + 2|VC|
∑
x∈VC
K(v, x) (6)
Note that if all K(v, v) are equal for all v, we can
further simplify (6) by removing its first term.
Nearest-neighbours score. If instead of considering
the average distance (1) between a vertex v and VC, we
consider the minimum distance between v and VC in
the feature space (2), we can derive in a similar way the
similarity measure SimNN:
SimNN(v, VC) = −min
x∈VC
[K(v, v) − 2K(v, x) + K(x, x)] (7)
If K(x, x) is equal for all x Î V, we can simplify (7),
thus achieving the nearest neighbours score SNN:
SNN(v, VC) = −min
x∈VC
−2K(v, x) = 2max
x∈VC
K(v, x) (8)
K-nearest-neighbours score. A natural extension of
the SNN score can be derived from the k-nearest neigh-
bours distance (3) of a vertex v from the set of nodes
VC, thus obtaining the k-nearest neighbours score SkNN:
SkNN(v, VC) = 2
∑
x∈Ik(v)
K(v, x) (9)
Any valid kernel K can be applied to compute the
above proposed scores, but in the context of Cancer
Module gene ranking, we used random walk kernels
[28], since they can capture the similarity between
genes, taking into account the topology of the overall
functional interaction network. Given a symmetric adja-
cency matrix W of the functional interaction undirected
graph G, the one-step random walk kernel is:
K = (a − 1)I +D− 12WD− 12 (10)
where K is the Gram matrix associated to the random
walk kernel function, whose elements kij correspond to
the values K(vi, vj) of the kernel function, I is the iden-
tity matrix, D is a diagonal matrix with elements
dii =
∑
j wij , and a is a value larger than 1.
In our experiments we applied q-step random walk
kernels K q-step = K
q, by varying the number of steps q
[28]. In this way we can explicitly evaluate the direct
neighbors of each gene (q = 1), but also its undirected
neighbors (e.g. q = 2 or q = 3). In other words, by set-
ting q = 2 or q = 3 two vertices are considered similar if
they are directly connected or if they are connected
through a path including one or two vertices. In princi-
ple also longer paths could be considered, but this could
introduce too remote similarities between genes, yield-
ing a potential high level of noise in the prediction of
Cancer Module genes.
It is worth noting that Vavien, a recently proposed
method applied to the gene ranking problem with
respect to OMIM diseases using protein-protein interac-
tion networks [29], shares some ideas, but also shows
significant differences with our approach. The general
setting of the problem is similar, but the realization of
the score function is very different: the Vavien algorithm
proposes a simple correlation measure between topolo-
gical profiles and the average profiles of genes known to
belong to a specific OMIM class, while we propose dif-
ferent score functions, based on different notions of dis-
tance, and the average distance that resembles the
Vavien average profile is realized in a more general Hil-
bert space, and represents only one of the possible dis-
tances that can be considered. From this standpoint our
approach could be considered a generalization of
Vavien: our method is not restricted to the classical cor-
relation measure to model the similarity between genes,
but different notions of similarity can be realized
through the proper choice of a kernel function: the cor-
relation can be applied by using a correlation kernel
[30], but other kernels representing different notions of
similarity between genes, (e.g. graph kernels [28] able to
capture the overall topology of the network), can be
embedded in the score functions to rank genes.
GeneMANIA
GeneMANIA [18] is a variant of the semi-supervised
learning algorithm originally proposed by Zhou et al.
[31], by which, adopting a “Gaussian smoothing”
approach labels associated to the vertices can be propa-
gated to rank the unlabeled vertices of the network.
Similarly to the previous method, GeneMANIA finds a
score S(vi) for each vi Î V , according to their likelihood
to belong to a given class VC, by minimizing the follow-
ing objective function:
S∗ = arg min
S
α
∑
i
(si − s0i )
2
+ (1 − α)
∑
i
∑
j
wij(si − sj)2 (11)
where S is the vector of the scores associated to the
genes, S0 is the initial vector of scores reflecting the a
priori knowledge about the investigated genes, si and s0i
their ith components, and wij are the elements of the
adjacency matrix W of the graph G connecting the
genes. Note that eq. (11) is the convex combination (0 ≤
a ≤ 1) of two terms, where the first one minimizes the
error between predicted and a priori known scores,
while the second assures the “internal coherence” of the
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network, by penalizing connected genes (i.e. pairs of
genes vi and vj with wij > 0) having different scores.
Equation (11) can be solved in closed form or through
efficient iterative algorithms (e.g. error minimization by
conjugate gradient techniques). GeneMANIA, originally
proposed to predict gene functions, differs from the ori-
ginal Zhou algorithm since it introduces a simple but
effective cost-sensitive technique (useful when the num-
ber of positive examples is largely lower than the total
number examples), and moreover applies a novel
weighted integration technique [32] (see “Networks inte-
gration” below).
Label propagation (LabelProp)
The Zhu et al. LabelProp (Label Propagation) [17] algo-
rithm minimizes an objective function that resembles
the previously described Zhou et al. algorithm:
S∗ = arg min
S
∑
i
∑
j
wij(si − sj)2 (12)
Eq. (12) corresponds to the second summation of eq.
(11), that assures an “internal coherence” of the com-
puted score (see previous subsection). The coherence w.
r.t. the initial score S0 is assured by not allowing any
change of the scores si for the vertices vi Î VC during
the label propagation process, that is the predicted
scores si are set to s0i for each vi Î VC. Also this algo-
rithm can be implemented both in closed form, or
through iterative techniques.
Networks integration
To integrate the FI and the HumanNet networks, we
summed their corresponding adjacency matrices, pre-
viously normalized according to a Laplacian graph nor-
malization, thus assuring the symmetry of the resulting
normalized matrix [28]. This method has been applied
to integrate the data with all the methods, but with Gen-
eMANIA we also used the SW algorithm, since it has
been introduced as part of an enhanced version of Gene-
MANIA [32]. In brief, SW integrated the networks
according to a weighted sum strategy, i.e. through a
weighted sum of the corresponding adjacency matrices
W(i):
W∗ =
∑
i
wiW
(i)
(13)
The weights wi are computed simultaneously for all
the considered classes by solving efficiently a single
ridge regression problem [32].
Results and discussion
After introducing the general set-up of the experiments,
we at first show that our proposed kernelized score
functions can successfully rank genes with respect to
CMs, using different sources of functional interaction
data, i.e. the FI and HumanNet functional networks (see
section “Functional interaction networks”), even if CMs
are defined mainly in terms of over or underexpressed
sets of genes. Then we compare our proposed kerne-
lized score functions with several state-of-the-art net-
work-based gene ranking methods, using both separated
FI and HumanNet data and an integrated data set con-
structed by combining the two functional networks.
Finally, we show that our methods could be applied to
discover novel genes associated to specific cancer types,
by analyzing whether top ranked “false positive” genes
for the CM 234 (Bone osteoblastic module) are actually
involved in the onset and progression of types of cancer
related to CM 234.
Experimental set-up
The genes belonging to the CMs defined in] [9] were fil-
tered in order to ensure the presence of at least one
functional interaction in both the FI and HumanNet
networks (see Methods): this led to the definition of a
final collection of 8499 human genes. We then removed
each Cancer Module annotated with less than 20 genes,
since our aim consists in assuring reliable predictions
and in showing the feasibility of our approach, obtaining
a final set of CMs composed of 298 distinct modules.
For each CM we ranked the genes with respect to
their likelihood to belong to the core set of genes anno-
tated to the considered module. Performance evaluation
was realized following a canonical 5-folds stratified
cross-validation (CV) scheme repeated 5 times. Perfor-
mances were collected in terms of precision at fixed
recall levels (ranging from 0.1 to 1.0 at 0.1 steps). We
also computed the area under the ROC curve (AUC) for
each CM. The results were averaged across the CV folds
and the repetitions of the experiment. We finally regis-
tered the computational times required by each method
for the completion of the entire experiment.
Ranking of genes using multi-source functional
interaction networks
We designed a set of experiments to show that CMs are
predictable using sources of data not limited to gene
expression profiles. More precisely our aim consists in
showing that we can rank genes with respect to a speci-
fic cancer module using protein-protein or domain-
domain interaction data included in the FI network, or
by using other functional interaction data obtained
through comparative genomics techniques as the ones
included in the HumanNet networks (see Methods for
more details on these networks). To this end, according
to the experimental set-up described in the previous
sections, we applied our newly proposed kernelized
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score functions SNN, SkNN and SAV, using 1, 2 and 3-
steps random walk kernels. AUC results presented in
Figure 2 show that the proposed methods are able to
rank genes with respect to cancer modules using func-
tional interaction networks constructed with different
sources of biomolecular data: independently of the score
function and the kernel adopted, the AUC values with
HumanNet are always significantly larger than 0.5 for
most of the 298 CMs. Similar results are obtained also
with the FI functional network (data not shown). These
results are also confirmed by the precision-recall curves
averaged across the 298 CMs (Figure 3 and 4), that
show that the kernelized score functions can reasonably
learn the cancer modules using FI and HumanNet
networks.
The proper choice of the optimal number of random
walk steps for the kernelized score functions is of critical
importance in order to obtain good performances. As we
can see in Figure 3 and 4, independently of the choice of
the kernelized score function and of the considered func-
tional interaction network, the best performance in terms
of precisions at fixed recall levels is obtained with 2-steps
random walk kernels. AUC results show that 2-steps ran-
dom walk kernels are the optimal choice also with
respect to this metric (Figure 2). We thus decided to use
only kernelized score functions based on 2-steps random
walk kernel in the subsequent analyses. The choice of the
optimal number of neighbours (the k parameter in SkNN)
was tuned by internal cross validation. We repeated the
entire experiment (using both the separated and inte-
grated networks) by varying k between 3 and 29. By aver-
aging across classes, we found that optimal average
results (both in terms of precision and AUC) are
obtained with k = 27. The a parameter of the kernel
functions (Section “Score functions based on kernelized
similarity measures”) has been set to 2 for all the ranking
tasks, after a preliminary evaluation of other values. It is
worth noting that both the score functions (i.e. the type
of score function) and the parameters of random walk
kernels (i.e. the number of steps, the a parameter and the
number of neighbours for SkNN) can be tuned e.g. by
internal cross validation separately for each CM. This is a
computationally intensive approach that could yield to
better results, but in principle it could be feasible consid-
ering that the proposed kernelized score functions are
very fast (see the section “Comparison of the empirical
time complexity” below).
The results show that functional similarities encoded in
interaction networks are thus useful to rank genes with
respect to cancer modules. In particular, direct and indir-
ect neighbours (coded respectively in 1 and 2-steps ker-
nels) are on the average the most informative to correctly
rank genes. Indeed 2-steps random walk kernels take into
account both direct links and nodes with path length
equal to 2 (indirect neighbours) to rank genes. If we
include in the score evaluation also nodes with path
Figure 2 Ranking of genes using the HumanNet functional interaction network: distribution of AUC results across the 298 Cancer
modules. From left to right boxplots refer to 1-step, 2-step and 3-step random walk kernels. Red boxplots correspond to SNN, green to SkNN and
blue to SAV kernelized score functions.
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Figure 3 Functional interactions network (FI): precision and recall curves relative to different kernelized score functions using random
walk kernels at 1, 2 and 3 steps. precisions, averaged across the 298 Cancer Modules, are computed through 5-fold cross-validation
techniques repeated 5 times for different fixed recall levels ranging from 0.1 to 1. SAV stands for Average score, SNN for Nearest-neighbor score and
SkNN for k-Nearest-neighbor score.
Figure 4 HumanNet network: precision and recall curves relative to different kernelized score functions using random walk kernels at 1,
2 and 3 steps. precisions, averaged across the 298 Cancer Modules, are computed through 5-fold cross-validation techniques repeated 5 times for
different fixed recall levels ranging from 0.1 to 1. SAV stands for Average score, SNN for Nearest-neighbor score and SkNN for k-Nearest-neighbor score.
Re and Valentini BMC Bioinformatics 2012, 13(Suppl 14):S3
http://www.biomedcentral.com/1471-2105/13/S14/S3
Page 8 of 16
length equal to 3 on the average we can observe a certain
decay in performance. A larger decay is observed with 4-
steps random walk kernels (data not shown). These
results show that similarities mediated through direct
common neighbours (2-steps) are the on the average the
most informative to predict CMs. Loose similarities,
represented by connections between genes mediated
through two or more other genes may add noise to the
learning process, thus resulting in reduced performance.
We need meaningful networks constructed with infor-
mative functional interactions between genes to cor-
rectly rank genes according to CMs. For instance, we
hypothesize that simple GO annotations to construct
similarity networks between genes are not enough to
predict whether a gene may belong to a specific cancer
module. To test this hypothesis we evaluated the perfor-
mances obtained by ranking the genes using directly as
input a network based on GO functional annotations
shared between genes. Using SAV with a 2 steps random
walk kernel we obtained an average precision close to
0:04 at recall 0.1, and this value decreases from recall
0:1 to 1:0 (data not shown). The poor performance
obtained with networks constructed from GO annota-
tions were also confirmed by AUC results, very close to
0.5, indicating, in practice, absence of learning. These
results are consistent with the process of definition of
the CMs, since even if many of them are composed of
subsets of one or more gene sets corresponding to func-
tional classes as encoded by GO or other functional
annotations repositories, CM design policies require that
all the members of the signatures constituting the core
of a CM must be up or down regulated [9].
Comparison of kernelized score functions with other gene
ranking methods
We compared our proposed kernelized score functions
SAV (Average score), SNN (Nearest neighbors score) and
SkNN (k-Nearest neighbors score) (see “Methods”) with
other semi-supervised machine learning methods for
gene ranking in biomolecular networks: GeneMANIA
[18,32], the semi-supervised network-based method pro-
posed by Zhou and others [33] (closely related to Gene-
MANIA), and the label propagation method (LabelProp),
proposed in [17] (see “Methods”). Results are presented
separately for the three functional interaction networks
(FI network, HumanNet network and the integrated
network).
Results using FI and HumanNet networks
Figure 5 (FI network) and Figure 6 (HumanNet net-
work) show the compared results obtained by the differ-
ent methods.
When using the functional relationships encoded in
the FI network (Figure 5), GeneMANIA performs slightly
better than all the other compared methods, with the
exception of precisions from 0.2 to 0.4 recall levels,
where results are very close to those obtained by SAV
and SkNN. The Zhou method (of which GeneMANIA can
be considered an enhanced version) performs worse
than GeneMANIA, SAV and SkNN in terms of precision,
but better than SNN. The worst performance in terms of
precision was obtained by LabelProp. All the precision
curves share the same trend (monotonically decreasing)
with the exception of the curve of LabelProp which
shows a maximum at recall 0.5.
When using the relationships encoded in the Human-
Net network (Figure 6), the best precisions at recall ran-
ging from 0.1 to 0.6 were obtained by SAV and SkNN while
the best precision in the 0.8 to 1.0 recall range are
obtained by GeneMANIA. The precisions of SAV, SkNN
and GeneMANIA are constantly above the ones of the
other methods. Also with this dataset LabelProp con-
firmed its poor performance: the main reasons of these
results depend on both the nature of this algorithm and
the characteristics of the functional interaction networks.
Indeed LabelProp propagates the initial labeling to all the
network by performing multiple iterations of the label
propagation before to converge to a stable solution. In
this way the algorithm explores also nodes very far from
the core of the initial positive nodes, and genes are con-
sidered similar even when paths connecting them are
relatively long; as a consequence, two genes become
“similar” when their functional similarities are relatively
loose, thus introducing noise in the transductive process
of gene ranking with respect to the CMs.
Results using the integrated functional interaction network
The FI and HumanNet networks contain complementary
information (see “Functional interaction networks”). We
thus produced an integrated network simply by summing
their adjacency matrices and we repeated our ranking
experiments. Compared precision performances are
depicted in Figure 7, while the averaged AUCs obtained
by each method in the ranking tasks performed using the
three functional networks are reported in Figure 8.
The best performing methods at low recall levels are SAV
and SkNN, indicating that in the investigated ranking tasks
they are the choice of election when relatively high preci-
sions are required by the application domain (Figure 7).
When we use the integrated network, the precisions of
SAV and SkNN lie above (or are equals to) the ones obtained
by GeneMANIA from 0:1 to 0:8 recall values and are
slightly worse at recall 0.9 and 1. In terms of precision at
low recall levels SAV outperforms SkNN: this holds until
recall 0.7. It is worth noting that in this context precision
at relatively low recall level is more significant, since to
assess by wet-based experiments whether top ranked “false
positive” genes are associated to a specific tumor, we
would like to know in advance that positive predictions
are actually positive (high precision), since usually wet-
Re and Valentini BMC Bioinformatics 2012, 13(Suppl 14):S3
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based experiments can be expensive in terms of costs and
time. Moreover at very high recall level the precision is
too low to be useful in practice (Figure 7).
According to the expectation that the information
encoded by the FI and HumanNet networks are, at least
in part, not overlapping, the ranking performances
obtained with the integrated network are better than
those obtained using either of the two component func-
tional networks for SAV and SkNN. It should be noticed
that with GeneMANIA we performed also a weighted
combination, according to the procedures described in
[32] (see Methods), but the results are statistically indis-
tinguishable from that obtained with the simpler
unweighted integration, and have been not reported in
Figure 7 and 8. Indeed, the weights assigned to FI and
HumanNet are approximately equal, and the resulting
integrated network is very close to that obtained
through the unweighted sum.
Figure 8 shows that for all but one (LabelProp) evalu-
ated methods, AUC, averaged across repetitions of the
experiments and all the CMs, increased after the inte-
gration of the functional interaction networks. In terms
of average AUC, the best performing methods are
LabelProp when we rank the genes using the FI net-
work, and SAV and SkNN with HumanNet and the inte-
grated network. With respect to the AUC, SkNN
obtained, on the average, results better than the ones
obtained by SAV in the test involving HumanNet and
the integrated network. To better evaluate if the
observed differences in terms of AUCs are significant,
we performed a Wilcoxon signed ranks sum test by
comparing the per CM AUCs averaged across the CV
folds and the repetitions using the integrated network.
This confirmed that SAV performs better than GeneMA-
NIA (p-value: 5.864×10-6), SkNN performs better than
both GeneMANIA (p-value: 1.162 ×10-7) and than SAV
(p-value: 1.332 × 10-6).
To assess the potential impact of the cardinality of the
CMs on the performance of the compared methods, we
analyzed the precision at 0.2 recall and the AUC for
CMs grouped by cardinality (Table 1). Kernelized score
functions achieve the best results among the compared
methods for the groups (20-100) and (101-200), that is
the groups including the CMs with a low or a relatively
low number of genes, independently of the considered
performance measure. Moreover our proposed method
Figure 5 FI network: comparison of precision and recall curves between our proposed kernelized score functions and other machine
learning methods for gene ranking. precisions, averaged across the 298 Cancer Modules, are computed through 5-fold cross-validation
techniques repeated 5 times for different fixed recall levels ranging from 0.1 to 1. SAV (Average score), SNN (Nearest-neighbor score) and SkNN (k-
Nearest-neighbor score) represent kernelized score functions. The parameter k of SkNN is set to 27. Zhou is the algorithm based on Gaussian
Random Fields proposed in [31] and GeneMANIA its variant, while LabelProp is the Label Propagation algorithm proposed in [17].
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Figure 6 HumanNet network: comparison of precision and recall curves between our proposed kernelized score functions and other
machine learning methods for gene ranking. precisions, averaged across the 298 Cancer Modules, are computed through 5-fold cross-
validation techniques repeated 5 times for different fixed recall levels ranging from 0.1 to 1. SAV (Average score), SNN (Nearest-neighbor score) and
SkNN (k-Nearest-neighbor score) represent kernelized score functions. The parameter k of SkNN is set to 27. Zhou is the algorithm based on Gaussian
Random Fields proposed in [31] and GeneMANIA its variant, while LabelProp is the Label Propagation algorithm proposed in [17].
Figure 7 Integrated network obtained by combining FI and HumanNet networks: comparison of precision and recall curves between our
proposed kernelized score functions and other machine learning methods for gene ranking. precisions, averaged across the 298 Cancer
Modules, are computed through 5-fold cross-validation techniques repeated 5 times for different fixed recall levels ranging from 0.1 to 1. SAV (Average
score), SNN (Nearest-neighbor score) and SkNN (k-Nearest-neighbor score) represent kernelized score functions. The parameter k of SkNN is set to 27. Zhou is
the algorithm based on Gaussian Random Fields proposed in [31] and GeneMANIA its variant, while LabelProp is the Label Propagation algorithm
proposed in [17].
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obtains the best AUC also for the group (201-300). On
the contrary GeneMANIA achieves the best results for
the group including CMs with the largest number of
genes, but note that SkNN achieves comparable results
also in the “301 and more” group of CMs. Among the
four cardinality groups the first one (20 to 100 positives)
accounts for about 70% of the 298 CMs involved in our
experimental setting, while each of the remaining car-
dinality groups covers about 10% of the 298 CMs.
Summarizing, results with integrated functional inter-
action networks show that the combined local and glo-
bal learning strategies embedded in kernelized score
functions lead to significantly better results that those
achieved by other compared methods. Moreover a fine
tuning of the choice of the score functions and of the
kernel parameters for each CM could yield to even bet-
ter results.
Comparison of the empirical time complexity
Table 2 reports the time required by each of the com-
pared methods for the realization of the entire experi-
ment (5-folds CV repeated 5 times for all the 298 CMs,
including pre-processing and normalization of net-
worked data), using an Intel i7-860 2.80 GHz processor
with 8 Gb of RAM. Our proposed methods are from ten
to several thousands times faster than the other com-
pared methods.
The proposed approach is very fast, since no model
learning is required, but only a computation of scores
based on kernelized distances: once the kernel matrix
Figure 8 Comparison of the AUCs (Area Under the Curve) between our proposed kernelized score functions and othe machine
learning methods for gene ranking, using FI, HumanNet and integrated networks. AUCs are averaged across all the modules and
estimated through 5-fold cross-validation repeated 5 times. SAV (Average score), SNN (Nearest-neighbor score) and SkNN (k-Nearest-neighbor score)
represent kernelized score functions. The parameter k of SkNN is set to 27. Zhou is the algorithm based on Gaussian Random Fields proposed in
[31] and GeneMANIA its variant, while LabelProp is the Label Propagation algorithm proposed in [17].
Table 1 Compared average performances grouped by
cardinality of CMs.
Precision at 0.2 recall
CMgroup SkNN GeneMANIA Zhou LabelProp
20 to 100 0.2040 0.1822 0.1872 0.0534
101 to 200 0.1851 0.1670 0.1607 0.0173
201 to 300 0.1792 0.1928 0.1991 0.0342
300 and more 0.2591 0.2620 0.2069 0.0359
average AUC
CMgroup SkNN GeneMANIA Zhou LabelProp
20 to 100 0.7990 0.7876 0.7779 0.7624
101 to 200 0.7149 0.7048 0.6773 0.6474
201 to 300 0.7267 0.7173 0.6804 0.6458
300 and more 0.7510 0.7525 0.6966 0.6213
Compared average precision at 0.2 recall and average AUC across 298 CMs
grouped by cardinality (number of genes included in the CMs) obtained by 5-
folds cross-validation repeated 5 times.
Table 2 Time requirements of the compared methods.
Method FI HumanNet Integrated network
SAV 200 196 195
SNN 202 212 203
SkNN 391 401 400
GeneMANIA 1906 1981 3321
Zhou 62875 63005 58420
LabelProp 609545 610520 606420
Time required for each of the compared methods for the realization of the
entire experiment (ranking of 8499 genes according to their likelihood to
belong to 298 CM, 5-folds CV repeated 5 times). Times are expressed in
seconds.
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has been computed, the score computation has a com-
plexity O(|V| · |VC|) , that is approximately linear when
the number of “positive” nodes is largely lower than the
overall number of vertices. In our experiments the num-
ber of genes in Cancer Modules is between 20 and
about 600, while the number of the overall genes is lar-
ger than 8000. Hence, in this setting our algorithm is
approximately linear with respect to the number of
genes.
A preliminary application to the discovery of novel genes
involved in the onset and progression of cancer
Since genes associated to CMs are detectable using also
data different from simple expression, we hypothesize
that mining more general functional interaction net-
works we could extract genes that are functionally
related to CMs, but whose functional interactions are
lost during the construction of the expression signature.
If this hypothesis is true, we expect that the top “false
positive” ranked genes associated to a given CM are on
the one hand functionally coherent, that is involved in
the same set (or, at least, in a restricted set) of biological
processes, and on the other hand pathologically coher-
ent (that is, involved in types of cancers where the CM
is activated or repressed). A thorough analysis of these
topics is beyond the scope of this paper, and would
require a specific study left for future research. Never-
theless in this section we present a preliminary test
restricted to the CM 234 (Bone osteoblastic module) to
show the potentialities of this approach. This choice is
motivated by the fact that this CM is the only one
described with a certain detail in the work of Segal and
colleagues [9] with more than 19 genes, and thus is pre-
sent in our experiments (we filtered out all the CMs
with less than 20 genes - see subsection “Experimental
set-up”).
Evaluation of the functional coherence of the CM 234 gene
ranking
The performance obtained by the compared methods in
the prediction of CM 234 genes are reported in Table 3.
According to the ranking obtained with SkNN, k = 27 (a
very similar ranking has been obtained with SAV), we
found that the first gene annotated in CM 234, (the
bone morphogenetic protein 7, BMP7) ranked only
tenth. The 9 top ranked “false positive” genes are:
NPR2, COL6A3, DLX6, COL1A2, NPPB, BMP6,
COL3A1, DLX2 and COL6A1, ranked in this order. To
evaluate the functional coherence of this set of genes,
we applied a functional profiling test of this list of 9
genes using gProfiler [34,35]. Results revealed that some
of the genes in this list are associated with the GO bio-
logical process (BP) term GO:0001501, skeletal system
development (p-value: 1.34×10-9), consistently to one of
the gene sets, skeletal development, initially involved in
the definition of CM 234. We also found a significant
functional association with the GO cellular component
(CC) terms GO:0005578, proteinaceous extracellular
matrix (p-value: 1.13 × 10-5) and GO:0030934, anchor-
ing collagen (p-value: 6.95 × 10-6). Moreover, a closer
look at the members of the gene sets involved in the
construction of CM 234 (see [36]) revealed that the
bone morphogenetic protein 6 (BMP6) was present in
the skeletal development gene set used in the construc-
tion of CM 234 but was not included in the final CM.
These observations confirmed the functional coherence
of these top-ranked genes, supporting the hypothesis
that the proposed method is able to discover genes that
are involved in the same biological processes repre-
sented by the considered expression signatures.
Evaluation of the pathological coherence of the CM 234
gene ranking
CM 234 is composed of genes involved in the prolifera-
tion and differentiation of bone-building cells [9]. The
genes included in this module were found to be induced
in arrays obtained from breast cancer, hepatocellular
carcinoma (HCC) and nontumor hepatitis-infected liver
samples [9]. Genes in this CM were also found to be
repressed in subsets of HCC, in a subset of acute lym-
phoblastic leukemia (ALL), and in a subset of lung can-
cer samples.
Details about the performance of the compared meth-
ods with respect to CM 234 are presented in Table 3.
This table shows the average precision at 0.2 and 0.4
recall, and the average AUC of the methods. In terms of
precision at both 0.2 and 0.4 recall the kernelized score
function achieve the best results, while in terms of aver-
age AUC GeneMANIA obtains slightly better results
than the other methods.
To test the pathological coherence of the list of the 9
top ranked “false positive” genes found by SkNN (see the
previous subsection), we mined the literature searching
for evidences suggesting that those genes are involved in
liver, breast, lung cancer or ALL. The equivalence of
gene names or symbols was assessed using the informa-
tion available for each gene in the Human Gene Com-
pendium [37]. COL6A3 was recently found to be
overexpressed in a study aimed at the investigation of
extracellular matrix dynamics in Hepatocarcinogenesis
Table 3 Performance of the compared methods for the
prediction of CM 234.
Method Prec. at 0.2 recall Prec. at 0.4 recall average AUC
GeneMANIA 0.0621 0.0547 0.8701
SkNN 0.2564 0.0900 0.8527
Zhou 0.1219 0.0829 0.8434
LabelProp 0.0212 0.0395 0.7483
Average precision at 0.2 and 0.4 recall and average AUC for the CM 234 (5-
folds CV repeated 5 times).
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in two mouse models [38], supporting the usefulness of
data derived from more than one species in the investi-
gated ranking tasks. The DLX gene family encodes for
homeobox transcription factors involved in the control
of morphogenesis and tissue homeostasis. A recent
work [39] reported evidences that DLX6 is activated
during metastasis formation in a breast cancer cell line.
An insertion/deletion polymorphism in the 3’ untrans-
lated region of type I collagen a2 (COL1A2) was
recently associated with susceptibility for HCC in a Chi-
nese population in [40]. In a recent work [41] the
authors described a molecular mechanism by which
BMP6 suppresses breast cancer metastasis. Another
recent work [42] reported that CpG islands in the
homeobox DXL2 gene are significantly more methylated
in a subtype (Luminal A) of breast tumors. A quantita-
tive analysis focused on the study of the lung cancer cell
secretome revealed that COL6A1 is a metastasis-asso-
ciated protein [43].
The 9 top ranked “false positive” genes predicted by the
Zhou method are NPPB, NPPC, NPPA, COL6A3, FN1,
COL3A1, NPR2, COL1A2 and FURIN (ranked in this
order). The COL6A3, COL3A1, COL1A2 and NPR2 genes
are also present in the top ranked prediction of our pro-
posed method. The natriuretic peptide precursor B
(NPPB) has been recently investigated as potential biomar-
ker in lung cancer [44]. The C-natriuretic peptide NPPC
can significantly decrease the number of small-cell lung
cancer cells as demonstrated in [45]. It was not possible to
found supporting literature for the association of NPPA
with the tumor types in which CM234 was found to be
activated or deactivated by Segal and colleagues. In [46]
FN1 was sought to be of prognostic value using a univari-
ate analysis of gene expression. FN1 was also bound to be
a potential biomarker for hepatocellular carcinomas in
[47]. FURIN is involved in the modulation of the activity
of the membrane type-1 matrix metalloproteinase (MT1-
MMP), an enzyme for which a protumorigenic action has
been recently observed [48] in breast cancer cells.
The 9 top ranked “false positive” genes predicted by
GeneMANIA are SFTPC, NPPB, CHRDL2, NPPC,
NPPA, DLX6, GALNT3, GLRB and DLX1 (ranked in
this order). Of these genes three (NPPA, NPPB and
NPPC) are also present in the list of top ranked false
positives predicted by the Zhou method while the DLX6
gene was also predicted as top ranked false positive by
our proposed method. Quite interestingly kernelized
score functions predicted as top ranked false positives
two members of the DLX genes family (DLX2 and
DLX6), while GeneMANIA predicted as false positive
another member of the family (DLX1). Among the false
positives predicted only by GeneMANIA, we observe
that GALNT3 is a target of the ERBB2 oncogene in
breast cancer [49].
The 9 top ranked “false positive: genes predicted by the
LabelProp method are GRB2, ACTB, PRKACA, SP1,
MAPK1, HSP90AA1, HSPA8, MAPK14 and SRC (ranked
in this order). In this case we found a less strict evidence
of association with the tumor types related to CM 234.
Moreover there is no overlap with “false positive” top
ranked genes of the other methods. This is not surprising
since this method behaves poorly with respect to both
precision at fixed recall and AUC (Table 3).
Summarizing, three of the considered methods (kerne-
lized score functions, GeneMANIA and Zhou) are able to
detect novel genes associated to cancer types related to
CM 234, but not included yet in CM 234 itself. These
results show that by exploiting functional interaction
data not limited to gene expression data, our proposed
kernelized score functions and other state-of-the-art gene
ranking network-based methods could be in perspective
applied to discover novel genes involved in different can-
cer types related to specific CMs, thus mitigating a ser-
ious problem affecting expression signature based
approaches: the difficulty in placing these signatures in a
wider biological context.
Conclusions
In this paper we applied state-of-the-art semi-supervised
machine learning methods to rank genes according to
their likelihood to belong to specific CMs, using gene
networks constructed from several sources of functional
interaction data, such as Reactome and other curated
pathways databases, physical protein-protein interactions,
proteins domain-domain interactions, protein interac-
tions obtained via biomedical text mining and Gene
Ontology annotations, and functional interactions
derived from yeast, fly and worm by means of a compara-
tive genomics approach.
Results show that using these integrated networks we
can successfully predict CMs defined mainly with
expression signatures obtained from gene expression
data profiling. In particular the integration of FI and
HumanNet networks leads to the best results, indepen-
dently of the method applied.
Our proposed kernelized score functions compare
favorably to state-of-the-art semi-supervised machine
learning methods, both in terms of average AUC and
precision at a fixed recall, at least for recall levels lower
than 0.7, where a meaningful precision can be achieved
in this difficult gene ranking task.
The substantial linearity of the proposed score func-
tions (that holds when the number of “positive” genes is
largely lower than the overall number of genes) assures
the scalability and applicability of the method to very
large gene networks, as shown also by its empirical
computational time, significantly lower with respect to
the other compared methods.
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Moreover, the analysis of the ranking results obtained
for the “Bone osteoblastic module” (CM 234), shows
that our approach is able to detect genes involved in
several types of cancer related to the same Cancer Mod-
ule, but not necessarily included in the Cancer Module
itself. These results show the potentiality of our pro-
posed methods for the discovery of novel genes involved
in the onset and progression of tumors related to CMs,
and a full genome study, extended to all CMs, is left for
future research.
Another possible research line could be the study of
learning strategies able to explicitly take into account
the similarities between different CMs. Indeed learning
a CM could be useful to better learn other related CMs
and some kind of knowledge transfer [29] or also multi-
task learning strategies could be explored in this
context.
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